Leila Ancelin — e/acc
3.8K posts

Leila Ancelin — e/acc
@leilaancelin
Product manager and e/acc | Ex startup founder | Product Builder :)
Strasbourg, France Katılım Ekim 2013
837 Takip Edilen764 Takipçiler

This is the final vision for my product hunt alternative.
Everything you see (chat, applauds, shares) will be real time for maximum fun experience.
Products were pre-validated by me, shown in random order each time to give exposure to all products.
Every maker gave me a huge exclusive discount for their product. You unlock all discounts at once by sharing the launch.
Every product is presented via a ~20min video interview I did with the maker.
All the interviews are recorded ✅
All backend code is done ✅
Server is ready ✅
I just need to code the CSS and do last checks 🔨
Add your email to the waitlist to not miss it (already 440+ subs)
itslaunchday.com coming soon.

English

@felixleezd @ycombinator Yay 🙋🏻♀️ interested Felix
English

Designers, YC is calling for you.
@ycombinator just put out a "request for startups" for more designer founders.
starting a group chat for designers who want to build their idea/startup... we’ll share:
- product ideas
- best frameworks and tools
- design engineering talks
- design founder chats
reply if you wanna join

English
Leila Ancelin — e/acc retweetledi
Leila Ancelin — e/acc retweetledi
Leila Ancelin — e/acc retweetledi

@leilaancelin No, but I know you can plug Stabe Diffusion to render your 3D scene on Blender.
English


@parmita Good luck Parm with your startup :) Did you need Product Manager in your area ?
English

*Regarding what we are creating, our fundraise, our people*
Here is a quick open update from me, Parm. Will also be on our soon-to-be updated website. Here you go:
Seven months ago, we set out to change how precision medicine works using optics and computational biology. Today, we know our first stop: drug discovery.
Traditional drug discovery is slow, expensive, and uncertain. It often relies on indirect evidence, leaving too many questions unanswered.
Meanwhile, computational approaches are often far too detached from the reality in a wet lab. Instead, they rely on very costly high throughput screens that leave little undisturbed. The biology is automated, screening as many times as possible, hoping to find luck across modalities.
We believed there was a better way: a simpler way. We found our answer in epigenetics.
Epigenetics dictates how genes behave without altering DNA itself. It deeply affects health, disease progression, and how effectively treatments work.
Yet, despite its critical role, the tools to understand epigenetic changes directly and quickly have been lacking.
Precigenetics was always short for Precision Epigenetics Technologies. We were always committed to epigenetics. Today, we announce our commitment starts on day 1.
We are developing and evaluating a unique approach - a “sensor intelligence”. Our technology combines state of the art biosensors, imaging, and AI to observe responses in real time. Not just this, but also, we screen, sort, and assay, all at the single-cell level. We aim to always capture heterogeneity.
Instead of guessing based on past data, we directly capture biology as it happens. This clarity speeds up discovery, cuts down uncertainty, and enables precise treatment.
The last six months have brought significant progress. We established our lab at MBC BioLabs, gained backing from respected investors like Chaotic Capital, O'Shaughnessy Ventures, and 1517 Fund, and welcomed world-class advisors from pharma, oncology, optics, and neurosurgery.
Today, we are solidifying our plans in stone. Establishing a go-to market with partnerships. We aim to have collaborations in 3 realms: hardware-side, intelligence-side and analytics platform-side. Eventually, our aim is to open source the outputs of some of our sensors. We can build in public, and take you with us in deciphering our data, open-source.
We have been actively designing our business plans in quiet, and expanding our team strategically. Recently, we announced our amazing Chief Business Officer. significantly enhancing our business potential. (We're also excited to soon announce another key hire: a renowned expert in computational chemistry and drug discovery.)
Our distinctive biosensor-driven method provides clarity by observing real-time cellular responses, eliminating uncertainty that plagues traditional discovery methods.
While our initial applications focus on precision epigenetics in oncology, the potential of our technology extends broadly across medical and biological fields.
Our initial technical validation has been shared at scientific conferences. We are always patenting and publishing more. We have been recognized by initiatives like the MissionLink cohort for 2025, in DC. We're building something ambitious, meaningful, and necessary.
With this, we are about to enter the crucial second leg of our fundraise. Our aim now, is to go all in. Develop our crazy tech. Make the dream come alive. In real time.
parm@precigenetics.com
English

@lexsalvator Yes it is new. We are entering in a new era :)
Did you try another softwares combined with AI to create things ?
English

@leilaancelin I am not suprised by this. 3D object are just array of coordinates. 1 year ago I asked ChatGPT to generate the text content of a .obj file (the 3D file extension), but it eventually refused each of my prompts.
Cool than Claude AI can now do it!
English

Wow impressive. What do you think ?
Brett Adcock@adcock_brett
We’re preparing to ship thousands of humanoid robots Here, we are showing 4x humanoid robots, each powered by its own Helix neural network
English

Especially in the startup world
Parmita Mishra@parmita
you find out by doing, not by thinking you figure it out by doing, not by thinking
English





